WHO confirms GLP-1 drugs can support long-term obesity care for adults – Benefits and Pensions Monitor

WHO confirms GLP-1 drugs can support long-term obesity care for adults  Benefits and Pensions MonitorWHO issues global guideline on the use of GLP-1 medicines in treating obesity  World Health Organization (WHO)WHO warning over shortage of obesity jabs  BBCWorld Health Organization issues first-ever guidelines for use of GLP-1 weight loss medications  ABC NewsShortage of ‘breakthrough’ weight loss drugs will slow fight against obesity, WHO warns  The Guardian